Deftbiotech

Hawthorn, Australia

Deftbiotech is a biotech startup developing peptide-based antifungal treatments for nail and skin infections.

$1.0M raised

Mar 2026

Pre-Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Deftbiotech raised?

Deftbiotech has raised $1.0M in total funding. The most recent round was Pre-Seed. The last funding was announced in March 2026.

Who are Deftbiotech's investors?

Deftbiotech's investors include La Trobe University, Breakthrough Victoria.

Where is Deftbiotech headquartered?

Deftbiotech is headquartered in Hawthorn, Australia.

What does Deftbiotech do?

Deftbiotech is a biotech startup developing peptide-based antifungal treatments for nail and skin infections.

What stage is Deftbiotech at?

Deftbiotech is at the Pre-Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 20, 2026.

MLA

"Deftbiotech — Funding & Investors." VCBacked, March 20, 2026, https://www.vcbacked.co/company/deftbiotech. Accessed July 3, 2026.

APA

VCBacked. (2026). Deftbiotech — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/deftbiotech

Wikipedia (cite web)

{{cite web |title=Deftbiotech — Funding & Investors |url=https://www.vcbacked.co/company/deftbiotech |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 20, 2026.